bibliographic resource 1860723 [br/1860723]
https://w3id.org/oc/corpus/br/1860723

is a
title
  • Evaluation of the EGFR-Inhibitor Zalutumumab Given With Primary Curative (Chemo)radiation Therapy to Patients With Squamous Cell Carcinoma of the Head and Neck: Results of the DAHANCA 19 Randomized Phase 3 Trial
publication date
  • 2014-01-01
contributor
format
identifier
part of